My research focuses on developing new and effective treatments for Alzheimer's disease as well as studying the cognitive and behavioral disturbances seen in mild cognitive impairment and early dementia. Our center is a major national site for clinical trials of experimental drugs for the treatment of Alzheimer's disease, including research on biomarkers of preclinical disease and secondary prevention approaches.